AdvanSource Biomaterials Corporation is a world-class polymer based materials company focused on customer-driven solutions for the medical device and pharmaceutical industries. Today’s devices are increasingly dependent upon material advancements and precise characteristics in order to optimize product performance. As such, AdvanSource Biomaterials continues to develop new and innovative technologies to meet the growing demands of the medical industry.

AMSilk has a unique process designed to biopolymers such as spider silk industrial scale manufacture. The first AMSilk ® technology enables the customer-specific production of different biomaterials, the conventional synthetic materials are often far superior. AMSilk serve many applications in different industrial areas with new materials to new and innovative products from it.

Bioretec products have their roots in biomaterials and implant technology. The research, started by a team led by Professor Pertti Törmälä at the Tampere University of Technology in 1977, was a success. As a result of the team’s work, the first surgical bone fracture fixation using a bioabsorbable fixation device was conducted in 1984 by Professor Rokkanen at Helsinki University Hospital. A bioabsorbable pin was used in the fixation of an ankle fracture in a female patient. Now Bioretec’s R&D team, led by Professor Törmälä, has created the fourth generation of bioabsorbable products, offering new and advanced properties combined with clear benefits for surgeons and patients. One of the key features of Bioretec’s products is their mechanical activity. A memory effect is based on the selected material combination, extensive research and far-ranging experience of material processing. The unique production process allows for medical-grade raw materials to be refined into a controlled and customized end product.

BONESUPPORT™ is a Swedish medical technology company dedicated to the development of injectable bone-like materials for the treatment of various defects, including fragility fractures caused by osteoporosis. Our vision is to be the world leader in the market for injectable, synthetic ceramic bone substitutes and injection accessories.